Onecrea Medical

Onecrea Medical is an early-stage, pre-revenue medical device company developing a novel TAVR system based on patented Cleveland Clinic technology. The company has assembled a world-class Scientific Advisory Board of renowned interventional cardiologists and cardiac surgeons to guide its development efforts. Operating in the highly competitive but rapidly growing structural heart market, Onecrea aims to introduce a next-generation valve that excels in performance. Its success hinges on advancing through preclinical and clinical development to ultimately secure regulatory approvals and market entry.

Patented transcatheter aortic valve replacement (TAVR) system technology licensed from the Cleveland Clinic, focused on next-generation design for improved safety and effectiveness.

The TAVR market is dominated by Edwards Lifesciences and Medtronic, with strong competition from Boston Scientific and Abbott. These incumbents have extensive clinical data, robust manufacturing, and entrenched commercial relationships. Onecrea must demonstrate clear clinical superiority or a compelling cost-benefit profile to overcome these barriers to entry.